Mankind Pharma and Innovent Collaborate to Improve Cancer Care Access in India
Mankind Pharma has announced a strategic partnership with Innovent Biologics to introduce Sintilimab, a PD-1 immunotherapy, to the Indian market….
Mankind Pharma has announced a strategic partnership with Innovent Biologics to introduce Sintilimab, a PD-1 immunotherapy, to the Indian market….
Cancer immunotherapy has revolutionized the treatment landscape for many patients battling various forms of cancer. By harnessing the body’s immune…
Immunotherapy has brought groundbreaking advancements in the treatment of metastatic melanoma, significantly improving long-term survival rates. Metastatic melanoma, which occurs…